title: 2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells.
abstract: Natural killer (NK) cells are lymphocytes that function as part of the innate immune system. Their activity is controlled by a range of inhibitory and activating receptors, including the important killer-cell immunoglobulin-like receptors (KIR). The KIR are a multi-gene family of receptors that interact with the human leukocyte antigen (HLA) class I family of molecules and are characterised by extensive allelic polymorphism. Their expression on the cell surface of NK cells is highly variable, but the factors responsible for this variability are not yet clearly understood. In the current study, we investigated KIR expression in a healthy human cohort that we had previously characterised in depth at a genetic level, with KIR allele typing and HLA class I ligand genotypes available for all donors (n=198). Allelic polymorphism significantly affected the phenotypic expression of all KIR analysed, whereas HLA ligand background influenced the expression levels of 2DL1 and 2DL3. In particular, we found that although 2DL2 may influence 2DL1 expression, this appears to be owing to variation in 2DL1 copy number. Finally, the inhibitory receptor LILRB1 had higher expression levels in individuals with B/B KIR genotypes, suggesting a possible relationship between KIR and non-KIR receptors, which serves to balance NK cell activation potential.
authors.affiliation: School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, 152-160 Pearse Street, Trinity College, Dublin 2, Ireland.
authors.forename: S E
authors.initials: SE
authors.lastname: Dunphy
authors.affiliation: Current address: BioAtlantis Ltd., Kerry Technology Park, Tralee, Co. Kerry, Ireland.
authors.forename: K J
authors.initials: KJ
authors.lastname: Guinan
authors.affiliation: School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, 152-160 Pearse Street, Trinity College, Dublin 2, Ireland.
authors.forename: C Ní
authors.initials: CN
authors.lastname: Chorcora
authors.affiliation: Cambridge Institute for Medical Research, University of Cambridge; Division of Immunology, Cambridge, UK.
authors.forename: J
authors.initials: J
authors.lastname: Jayaraman
authors.affiliation: 1] Cambridge Institute for Medical Research, University of Cambridge; Division of Immunology, Cambridge, UK [2] Department of Pathology, University of Cambridge, Cambridge, UK.
authors.forename: J A
authors.initials: JA
authors.lastname: Traherne
authors.affiliation: Department of Pathology, University of Cambridge, Cambridge, UK.
authors.forename: J
authors.initials: J
authors.lastname: Trowsdale
authors.affiliation: Immunology Laboratory, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, Genova, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Pende
authors.affiliation: Transplant Immunology Laboratory, Royal Liverpool University Hospital, Liverpool, UK.
authors.forename: D
authors.initials: D
authors.lastname: Middleton
authors.affiliation: School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, 152-160 Pearse Street, Trinity College, Dublin 2, Ireland.
authors.forename: C M
authors.initials: CM
authors.lastname: Gardiner
mesh_terms: D000483:Alleles; D006801:Humans; D007694:Killer Cells, Natural / Q000378:metabolism*; D010641:Phenotype; D011110:Polymorphism, Genetic; D054340:Receptors, KIR / Q000235:genetics* / Q000378:metabolism
chemical_list: D054340:Receptors, KIR